Mineralys Therapeutics (MLYS) Financial Statements

Price: $12.4
Market Cap: $778.53M
Avg Volume: 1.01M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: -0.394
52W Range: $8.241-18.38
Website: Mineralys Therapeutics

Overview of Financial Statements

Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:

  • Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
  • Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
  • Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.

This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Mineralys Therapeutics.


Income Statement

Revenue
Cost of Revenue
Revenue and Costs$2.00$2.00$1.60$1.60$1.20$1.20$0.80$0.80$0.40$0.40$0.00$0.0020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Operating Expenses
Operating Income
Operating Expenses & Income$200.00M$200.00M$100.00M$100.00M$0.00$0.00-$100.00M-$100.00M-$200.00M-$200.00M20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Revenue $- $- $- $- $-
Cost of Revenue $- $- $- $- $-
Gross Profit $- $- $- $- $-
Gross Profit Ratio 0.00% 0.00% 0.00% 0.00% 0.00%
Research and Development Expenses $168.58M $70.36M $26.25M $16.31M $2.41M
General and Administrative Expenses $23.82M $14.30M $5.23M $2.42M $532.00K
Selling and Marketing Expenses $- $- $- $- $-
Selling General and Administrative Expenses $23.82M $14.30M $5.23M $2.42M $532.00K
Other Expenses $- $- $4.00K $1.00K $-1.00K
Operating Expenses $192.40M $84.66M $31.48M $18.73M $2.94M
Cost and Expenses $- $84.66M $31.48M $18.73M $2.94M
Interest Income $- $12.76M $1.68M $- $-
Interest Expense $- $- $1.68M $27.00K $115.00K
Depreciation and Amortization $- $- $228.49K $18.73M $2.94M
EBITDA $-192.40M $-84.66M $-31.48M $- $-
EBITDA Ratio - - - 0.00% 0.00%
Operating Income $-192.40M $-84.66M $-31.48M $-18.73M $-2.94M
Operating Income Ratio - - - - -
Total Other Income Expenses Net $14.59M $12.76M $1.68M $-683.00K $-483.00K
Income Before Tax $-177.81M $-71.90M $-29.80M $-19.41M $-3.43M
Income Before Tax Ratio - - - - -
Income Tax Expense $- $- $-1.90M $27.00K $115.00K
Net Income $-177.81M $-71.90M $-29.80M $-19.41M $-3.43M
Net Income Ratio - - - - -
EPS $-3.66 $-1.99 $-0.73 $-0.50 $-0.09
EPS Diluted $-3.66 $-1.99 $-0.73 $-0.50 $-0.09
Weighted Average Shares Outstanding 48.54M 36.19M 40.86M 39.06M 39.06M
Weighted Average Shares Outstanding Diluted 48.54M 36.19M 40.86M 39.06M 39.06M
SEC Filing Source Source Source Source Source

Balance Sheet

Total Assets
Total Liabilities
Total Assets and Liabilities$300.00M$300.00M$240.00M$240.00M$180.00M$180.00M$120.00M$120.00M$60.00M$60.00M$0.00$0.0020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Equity$280.00M$280.00M$210.00M$210.00M$140.00M$140.00M$70.00M$70.00M$0.00$0.00-$70.00M-$70.00M20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents $114.09M $49.30M $87.70M $10.61M $1.41M
Short Term Investments $84.10M $187.26M $22.41M $- $-
Cash and Short Term Investments $198.19M $236.57M $110.11M $10.61M $1.41M
Net Receivables $- $- $- $- $-
Inventory $- $- $- $- $-
Other Current Assets $7.16M $12.54M $2.70M $460.00K $57.00K
Total Current Assets $205.35M $249.10M $110.11M $11.12M $1.47M
Property Plant Equipment Net $53.00K $- $- $- $-
Goodwill $- $- $- $- $-
Intangible Assets $- $- $- $- $-
Goodwill and Intangible Assets $- $- $- $- $-
Long Term Investments $- $2.48M $- $- $-
Tax Assets $- $- $- $- $-
Other Non-Current Assets $499.00K $51.00K $4.33M $3.00K $20.00K
Total Non-Current Assets $552.00K $2.53M $4.33M $3.00K $20.00K
Other Assets $- $- $0 $- $-
Total Assets $205.90M $251.64M $114.44M $11.12M $1.49M
Account Payables $479.00K $601.00K $1.91M $763.00K $529.00K
Short Term Debt $- $- $- $- $4.50M
Tax Payables $- $- $- $- $-
Deferred Revenue $- $- $- $- $-
Other Current Liabilities $14.17M $9.88M $6.16M $4.29M $54.00K
Total Current Liabilities $14.65M $10.48M $8.07M $5.05M $5.08M
Long Term Debt $- $- $- $- $-
Deferred Revenue Non-Current $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $-
Other Non-Current Liabilities $- $- $- $- $-
Total Non-Current Liabilities $- $- $158.64M $29.00M $-
Other Liabilities $- $- $- $- $-
Total Liabilities $14.65M $10.48M $166.71M $34.05M $5.08M
Preferred Stock $- $- $158.64M $29.00M $-
Common Stock $5.00K $4.00K $1.00K $1.00K $1.00K
Retained Earnings $-302.52M $-124.71M $-52.81M $-23.01M $-3.60M
Accumulated Other Comprehensive Income Loss $- $- $-158.64M $-0 $0
Other Total Stockholders Equity $493.77M $365.86M $52.81M $-29.00M $5.00K
Total Stockholders Equity $191.26M $241.15M $-52.27M $-22.93M $-3.60M
Total Equity $191.26M $241.15M $-52.27M $-22.93M $-3.60M
Total Liabilities and Stockholders Equity $205.90M $251.64M $114.44M $11.12M $1.49M
Minority Interest $- $- $- $- $-
Total Liabilities and Total Equity $205.90M $251.64M $114.44M $11.12M $1.49M
Total Investments $84.10M $189.75M $22.41M $- $-
Total Debt $- $- $- $- $4.50M
Net Debt $-114.09M $-49.30M $-87.70M $-10.61M $3.09M

Cash Flow Statement

Operating Cash Flow
Investing Cash Flow
Operating and Investing Cash Flow$140.00M$140.00M$70.00M$70.00M$0.00$0.00-$70.00M-$70.00M-$140.00M-$140.00M-$210.00M-$210.00M20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Financing Cash Flow$250.00M$250.00M$200.00M$200.00M$150.00M$150.00M$100.00M$100.00M$50.00M$50.00M$0.00$0.0020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Net Income $-177.81M $-71.90M $-29.80M $-19.41M $-3.43M
Depreciation and Amortization $43.00K $- $- $- $-
Deferred Income Tax $- $- $- $- $-
Stock Based Compensation $11.34M $5.06M $455.00K $80.00K $1.00K
Change in Working Capital $9.52M $-7.47M $772.00K $4.08M $480.00K
Accounts Receivables $424.00K $- $- $- $-
Inventory $- $- $- $- $-
Accounts Payables $- $- $3.01M $- $-
Other Working Capital $9.10M $-7.47M $772.00K $4.08M $480.00K
Other Non Cash Items $-9.40M $-6.87M $-649.00K $684.00K $482.00K
Net Cash Provided by Operating Activities $-166.31M $-81.17M $-29.22M $-14.56M $-2.46M
Investments in Property Plant and Equipment $-96.00K $- $- $- $-
Acquisitions Net $- $- $- $- $-
Purchases of Investments $-373.44M $-347.97M $-71.76M $- $-
Sales Maturities of Investments $488.50M $187.50M $50.00M $- $-
Other Investing Activities $- $- $-21.76K $- $-
Net Cash Used for Investing Activities $114.96M $-160.47M $-21.76M $- $-
Debt Repayment $- $- $- $- $-
Common Stock Issued $116.06M $202.99M $- $23.81M $-20.00K
Common Stock Repurchased $- $- $-1.63M $- $-20.00K
Dividends Paid $- $- $- $- $-
Other Financing Activities $83.00K $516.00K $129.65M $23.81M $3.83M
Net Cash Used Provided by Financing Activities $116.14M $203.25M $128.02M $23.81M $3.83M
Effect of Forex Changes on Cash $- $- $- $- $-
Net Change in Cash $64.79M $-38.40M $77.04M $9.25M $1.37M
Cash at End of Period $114.09M $49.30M $87.70M $10.66M $1.41M
Cash at Beginning of Period $49.30M $87.70M $10.66M $1.41M $42.00K
Operating Cash Flow $-166.31M $-81.17M $-29.22M $-14.56M $-2.46M
Capital Expenditure $-96.00K $- $- $- $-
Free Cash Flow $-166.41M $-81.17M $-29.22M $-14.56M $-2.46M